Effect of transcutaneous auricular vagal nerve stimulation on the fatigue syndrome in patients with gastrointestinal tumors

Phase 4

Recruiting

• Conditions: G93.3; F32; Postviral fatigue syndrome; Depressive episode

• Registration Number: DRKS00027481
• Lead Sponsor: niversitätsklinikum Knappschaftskrankenhaus Bochum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

(1) patients during or after therapy of a gastrointestinal tumor
(2) prognosis >1 year
(3) clinically apperent CRF on Hornheider Assessment scale
(4) age >18
(5) no or stable depression for at least 4 weeks

Exclusion Criteria

(1) severe psychiatric disease (e.g. scizophrenia)
(2) >8 scores on NGASR-questionnaire
(3) active vagal nerve stimulation oder s.p. vagotomy
(4) relevant cardiac disease (e.g. bradycardic arrhythmia, severe insufficiency, s.p. infarction)
(5) active implantat, ventricular shunt
(6) inability to understand study
(7) progressive neurologic disease (e.g. Parkinson's, MS, epilepsia)
(8) pregnancy
(9) prostate-carcinoma
(10) relevant dermatologic disease at the ear
(11) anatomic anomalia of the ear preventing use of electrode
(12) relevant other disease which prevents participation

Study & Design

• Study Type: interventional
• Study Design: Not specified